Yu Yan
Fujian University of Traditional Chinese Medicine(CN)Central South University(CN)Harbin Medical University(CN)Beijing University of Chinese Medicine(CN)Capital Medical University(CN)Sichuan University(CN)China Rehabilitation Research Center(CN)Third Affiliated Hospital of Harbin Medical University(CN)Chinese Institute for Brain Research(CN)Third Xiangya Hospital(CN)Xiangya Hospital Central South University(CN)
Publications by Year
Research Areas
Advanced Glycation End Products research, Ferroptosis and cancer prognosis, Computational Drug Discovery Methods, Tryptophan and brain disorders, RNA modifications and cancer
Most-Cited Works
- → The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents(2015)476 cited
- HMGB1 regulates erastin-induced ferroptosis via RAS-JNK/p38 signaling in HL-60/NRASQ61L cells.(2019)
- → IGF2BP2-modified circular RNA circARHGAP12 promotes cervical cancer progression by interacting m6A/FOXM1 manner(2021)82 cited
- → Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2(2022)77 cited
- → S100A8 Contributes to Drug Resistance by Promoting Autophagy in Leukemia Cells(2014)74 cited
- → Risk Factors, Prognostic Factors, and Nomograms for Distant Metastasis in Patients With Newly Diagnosed Osteosarcoma: A Population-Based Study(2021)72 cited